Circulation Research

Circulation Research is a biweekly, peer-reviewed journal covering fundamental cardiovascular science, published by Lippincott Williams & Wilkins for the American Heart Association since 1953 and reporting a 2025 Journal Impact Factor of 18.0（Circulation Research）是由（Lippincott Williams & Wilkins）代表（American Heart Association）出版的同行评审期刊，双周出版，聚焦心血管基础科学，1953 年创刊，2025 年影响因子为 18.0。

Scope

• It is a forum for fundamental, mechanistic research relevant to the cardiovascular system across many disciplines该刊是心血管系统基础机制研究的论坛，涉及多个学科。
• These disciplines include biochemistry, biophysics, cellular biology, molecular biology and genetics这些学科包括生物化学、生物物理、细胞生物学、分子生物学与遗传学。
• They also include pathology, physiology and pharmacology of the heart and vessels还包括心脏与血管的病理学、生理学与药理学。
• It publishes high quality work on basic cardiac and vascular biology and welcomes state of the art mechanistic approaches该刊刊载心脏与血管基础生物学的高质量研究，并欢迎采用前沿方法揭示机制的工作。
• Translational research and clinical research that yields fundamental insight are especially welcome特别欢迎能带来基础性洞见的转化研究与临床研究。
• Studies in humans or human tissues that advance understanding of disease and therapy are emphasized尤为重视在人体或人体组织中开展、加深对疾病与治疗认识的研究。
• Editorial features include Original Contributions, Short Communications, Brief UltraRapid Communications and New Methods in Cardiovascular Biology栏目包括原创论文（Original Contributions）、短通讯（Short Communications）、超快速简报（Brief UltraRapid Communications）与心血管生物学新方法。
• Further features are Editorials and Commentaries, Thematic Review Series, News & Views and Profiles in Cardiovascular Science其他栏目还有社论与评论、主题综述系列、新闻与观点以及心血管科学人物。

History

• It was established in 1953 by the American Heart Association, with Carl J. Wiggers as its first Editor-in-Chief该刊于 1953 年由（American Heart Association）创办，首任主编为（Carl J. Wiggers）。
• It is published by Lippincott Williams & Wilkins, part of Wolters Kluwer, on behalf of the American Heart Association该刊由（Lippincott Williams & Wilkins）（Wolters Kluwer）代表（American Heart Association）出版。
• It appears biweekly, giving around two dozen issues a year该刊双周出版，每年约二十余期。
• It is a hybrid journal in which authors may pay for open access under a CC BY-NC-ND license该刊为混合期刊，作者可付费开放获取，开放获取论文采用 CC BY-NC-ND 许可。
• Its Journal Impact Factor was 17.4 in 2021, 23.2 in 2022, 16.2 in 2024 and 18.0 in 2025其影响因子 2021 年为 17.4，2022 年为 23.2，2024 年为 16.2，2025 年为 18.0。
• It is indexed in SCIE, Scopus and PubMed, ranking Q1 in Peripheral Vascular Disease with a 2025 JIF rank of 2 out of 100该刊被（SCIE）（Scopus）与（PubMed）收录，在外周血管病类别为 Q1，2025 年 JIF 排名为 100 名中的第 2。
• It has published landmark highly cited reviews such as one on endothelial dysfunction and atherosclerosis该刊刊载了众多高被引经典综述，例如关于内皮功能障碍与动脉粥样硬化的综述。^[1]

Editors

• Its current Editor-in-Chief is Jane E. Freedman, MD现任主编为（Jane E. Freedman），医学博士。
• Its first Editor-in-Chief was Carl J. Wiggers, who served from January 1953 to December 1957首任主编为（Carl J. Wiggers），任期为 1953 年 1 月至 1957 年 12 月。
• The journal is owned by the American Heart Association and editorial decisions are made by the editor and associate editors该刊归（American Heart Association）所有，编辑决定由主编与副主编团队作出。
• Its associate editors include Huang Yu of the Chinese University of Hong Kong副主编包括（Chinese University of Hong Kong）的（Huang Yu）。
• Consulting Editors include Junichi Sadoshima and Stephen F. Vatner顾问编辑包括（Junichi Sadoshima）与（Stephen F. Vatner）。
• The editorial team draws on cardiovascular scientists and clinicians from many countries编辑团队汇聚来自多个国家的心血管科学家与临床医生。